Cell Summit Highlights Need for Integrated CGT Ecosystem
The July 2026 Cell Summit focused on building a coordinated system to bring cell and gene therapies from lab to patients.
17 Oct 2026 0 reads Compiled with AI
#BioLife Solutions #CGT #Cell Summit #Cincinnati #Cincinnati Children’s Hospital #GEN
In July 2026, BioLife Solutions hosted the second annual Cell Summit in Cincinnati, Ohio, bringing together leaders from the cell and gene therapy (CGT) field. The goal was to discuss how to move therapies from laboratory success to reliable patient treatment. Speakers, clinicians, manufacturers, and policymakers met to identify the hurdles that stand between scientific proof and patient access.
Collaboration drives scalable delivery
Roundtable discussions covered scale‑up, supply chain, reimbursement, and data governance. Attendees agreed that scaling CGT requires an integrated operating system, not isolated workstreams. Each link—patient identification, manufacturing, delivery, treatment, outcome, and economics—must function together; a failure in any part delays care and weakens the commercial model.
The summit produced a proceedings eBook, co‑authored with GEN and Cincinnati Children’s Hospital, that summarizes lessons and poses the question: what must be true for CGT to become repeatable and sustainable? The meeting underscored that collaboration is essential, and that success is measured when a therapy reaches and benefits the patient, not just when it leaves the factory.